Skip to main navigation

Overview
News & Events
- News Releases
- Events & Presentations
Governance
Financials
- SEC Filings
- IRS Form 8937
Stock
Resources

News Releases

Year

09 Dec '24

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline

27 Nov '24

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

17 Nov '24

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024

08 Nov '24

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

07 Nov '24

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

05 Nov '24

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

30 Oct '24

Carisma Therapeutics Announces Changes to its Board of Directors

04 Oct '24

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024

10 Sep '24

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases

03 Sep '24

Carisma Therapeutics to Present at Upcoming Conferences

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Displaying 1 - 10 of 31

Site - Investor Tools

Print Page
Email Alerts
RSS Feeds
IR Contact

Request Email Alerts

© 2025 Carisma Therapeutics Inc. All rights reserved.